Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Takeda discloses anti-Ureaplasma agents

Sep. 27, 1996

U.S. and Canadian researchers report fungicidal conjugated styryl ketones

Sep. 27, 1996

Bayer claims naphthyridine derivatives

Sep. 27, 1996

Generic cefaclor approved in the U.S.

Sep. 27, 1996

Takeda develops new pediatric formulation of Firstcin

Sep. 27, 1996

New tablet formulation of valaciclovir

Sep. 20, 1996

Sixteenth approval for Amphotec

Sep. 20, 1996

New topical triazole antifungal agent from Kaken

Sep. 20, 1996

Optically active triazole antifungal agent from Takeda

Sep. 20, 1996

Antifungal cyclohexapeptides from Merck & Co.

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...